COVID-19 Vaccines Now Available for Children Aged 5-11
Parents all over the world can finally breathe a sigh of relief as the US FDA has authorized the emergency use of Pfizer-BioNTech COVID-19 vaccine for children aged 5 to 11, bringing hope to an age group that has been hit hard by the pandemic.
The authorization came after Pfizer submitted data from a clinical trial that showed the vaccine to be safe and effective in this age group. The trial involved more than 2,200 children and the results showed that the vaccine was 90.7% effective in preventing symptomatic COVID-19 infections.
With the approval of the vaccine for children aged 5-11, parents can now have peace of mind knowing that their little ones are protected against the virus. Children, who previously had no protection other than masks and social distancing, can now benefit from the vaccine’s protection against the deadly virus.
The roll-out of the vaccine for children is expected to start in the coming weeks, and parents are encouraged to get their children vaccinated as soon as possible. The Pfizer vaccine requires two doses, administered 21 days apart, and the company is working to provide lower doses of the vaccine specifically for children.
Conclusion
The authorization of the COVID-19 vaccine for children aged 5-11 is a major milestone in the fight against the pandemic. Parents can now protect their children from the virus, and with more and more people getting vaccinated, we can hope to put an end to the pandemic once and for all.
